| dimethyl sulfoxide |
drug |
5 |
2 |
DMSO, dimethylsulfoxide, vehicle |
| dipoles |
drug |
2 |
1 |
|
| disability |
phenotype |
5 |
2 |
Disability score |
| DISC1 |
gene |
8 |
7 |
DISC1 L, DISC1 L isoform, DISC1 locus, Disrupted in Schizophrenia 1, Disrupted in schizophrenia 1, Disrupted-in-Schizophrenia 1, TRAX/DISC1, disrupted in schizophrenia 1 |
| discipline |
phenotype |
2 |
1 |
control, disciplined |
| discovery dataset |
cohort |
7 |
3 |
discovery |
| discovery GWAS |
cohort |
8 |
5 |
GWAS, discovery GWAS |
| discovery sample |
cohort |
21 |
16 |
106,336 out of 133,653 individuals, Nd, appropriate discovery cohort, discovery cases, discovery cohort, discovery sample, enrichment cohort |
| discrimination |
phenotype |
8 |
4 |
anticipatory ethnic discrimination, discrimination, ethnic discrimination, experiences with discrimination, exposure to discrimination, major experiences of discrimination, perceived discrimination, prejudice, race and discrimination, race discrimination, racial discrimination, racial prejudice, racialization, racialized, racialized discrimination, racialized prejudice, racism, social discrimination, stigma-related discrimination, stigma-related stressor, unfair treatment |
| disease |
phenotype |
60 |
32 |
GWAS of diseases, affection status, disease, disorder, health outcomes, over 200 diseases, phenotype, the disease, trait |
| disease-associated SNPs |
cohort |
2 |
— |
disease SNPs |
| disease-associated variant |
variant |
3 |
2 |
common variant, disease-associated variant, disease-associated variants |
| disease burden |
phenotype |
3 |
1 |
DALYs, burden of disease, disease burden, global disease burden |
| disease genes |
gene |
6 |
1 |
|
| disease outcome |
phenotype |
2 |
— |
disease outcome |
| disease phenotypes |
phenotype |
4 |
— |
|
| disease prevalence |
phenotype |
3 |
2 |
K |
| disease progression |
phenotype |
10 |
1 |
disease progression |
| disease risk |
phenotype |
11 |
5 |
disease risk, disease risks |
| disease state |
phenotype |
2 |
1 |
disease |
